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Abstract
Objective To determine comparative safety and effectiveness of
combinations of bearing surfaces of hip implants.
Design Systematic review of clinical trials, observational studies, and
registries.
Data sources Medline, Embase, Cochrane Controlled Trials Register,
reference lists of articles, annual reports of major registries, summaries
of safety and effectiveness for pre-market application and mandated
post-market studies at the United States Food and Drug Administration.
Study selection Criteria for inclusion were comparative studies in adults
reporting information for various combinations of bearings (such as metal
on metal and ceramic on ceramic). Data search, abstraction, and
analyses were independently performed and confirmed by at least two
authors. Qualitative data syntheses were performed.
Results There were 3139 patients and 3404 hips enrolled in 18
comparative studies and over 830 000 operations in national registries.
The mean age range in the trials was 42-71, and 26-88% were women.
Disease specific functional outcomes and general quality of life scores
were no different or they favoured patients receiving metal on
polyethylene rather than metal on metal in the trials. While one clinical
study reported fewer dislocations associated with metal on metal
implants, in the three largest national registries there was evidence of
higher rates of implant revision associated with metal on metal implants
compared with metal on polyethylene. One trial reported fewer revisions
with ceramic on ceramic compared with metal on polyethylene implants,
but data from national registries did not support this finding.
Conclusions There is limited evidence regarding comparative
effectiveness of various hip implant bearings. Results do not indicate
any advantage for metal on metal or ceramic on ceramic implants
compared with traditional metal on polyethylene or ceramic on
polyethylene bearings.
Introduction
Every year over 700 000 joint replacements are performed in
the Unites States alone,
1 of which over 270 000 are hip
replacements. The annual volume of hip joint replacement is
projected to double over the next decade. Moreover, these
surgeries are expected to become more expensive with total
costs tripling in just five years.
2 While joint replacement is a
successfuloperationanddealswithagreatpublichealthburden,
substantialnumbersofpatientswhoreceivehipimplantsrequire
revision surgery within 10 years to replace the implant because
of infection, dislocation, wear, instability, loosening, or other
mechanical failures.
3-6 The bearing/articulating surface is
designedtoendurethecontactstressandisoneofthekeydesign
factors to reduce the complications and the chance of revision.
Hip implants with metal femoral heads with polyethylene cups
asarticulatingsurfacesareassociatedwithlowratesofrevision.
7
Nationalregistriesthroughouttheworldcontinuereportinglow
risk of revision with this traditional bearing.
8-10 On the other
hand,rapidgrowthoftechnologyintroducedseveralalternative
bearingstothemarketthataimedtofurtherreduceimplantwear
andsubsequentlythetimetorevisionsurgery.Thesealternatives
include metal on metal and ceramic on ceramic bearings.
11
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Research
RESEARCHMetal on metal bearings are particularly attractive to surgeons
as they allow use of larger femoral heads (>32 mm v <32 mm)
and supposedly reduce the risk of dislocation and improve the
functionaloutcomesinyoungerpatients.
12 13Theywerequickly
adopted by surgeons and often used even in older patients. In
onestudy,oneoutofthreeolderpatientsundergoinghipsurgery
received metal on metal hip implants.
2 Recently, however, the
United Kingdom regulatory agency (Medicines and Healthcare
Products Regulatory Agency) alerted the public about severe
cases of metallosis (accumulation of metal ions in the tissues)
related to the release of metal ions from the implants,
14 and the
British Orthopaedic Association developed specific
recommendations.
11 Furthermore, in August 2010 Johnson and
Johnson recalled over 93 000 metal on metal implants called
“ASR.”
15 16TherecallreceivedwidespreadcoverageintheNew
YorkTimes,
17andtheBritishMedicalJournalpublishedpapers
relatedtodeviceregulation,clinicianinvolvement,andtheneed
to develop evidence.
16 18
In the US, the Food and Drug Administration has been closely
monitoring reports of failure of hip implants related to various
bearing surfaces and, in November 2009, initiated a
comprehensiveevaluationandsynthesisofevidenceofreported
outcomes for approved implants. We systematically reviewed
the evidence to determine the short and long term outcomes
reported by patients undergoing hip replacement and the rates
of revision after use of implants with various bearings.
Methods
Identification of studies
We worked with the Food and Drug Administration to identify
the summaries of safety and effectiveness for all pre-market
application trials and relevant Food and Drug Administration
mandatedpost-marketstudiesreportingcomparativeinformation
for hip implants. Summaries of safety and effectiveness of all
ceramic on ceramic hip implants are publicly available as these
were the only pre-market application hip replacement devices.
Wethenidentifiedallrelevantpublicationsrelatedtopre-market
application trials in Medline, Embase, and the Cochrane
Controlled Trials Register to learn about long term results (any
follow-up) reported. Additionally, we performed a
comprehensive search of all other publications in Medline,
Embase, and the Cochrane Controlled Trials Register from
January 1995 to June 2011. We used all MeSH terms
corresponding to hip bearing surface as well as any text words
thatwereapplicabletolocatethestudies.Thesystematicsearch
strategyisoutlinedinappendix1onbmj.com.Wealsosearched
the reference lists of trials and reviews for additional studies.
Finally, we reviewed the online annual reports of all registries
(within and outside the US) that report information from their
registry (see appendix 2 on bmj.com for details).
WelimitedourstudytopapersinEnglish.Ourinclusioncriteria
were clinical studies, only adults enrolled, reporting any one of
the clinical outcomes of interest (any functional outcomes or
revisions, or both), and conventional hip replacement.
Abstraction of data
The data were independently abstracted and checked multiple
times by two abstractors (SD, SJ). The senior author (AS)
resolved any discrepancies. Both SD and SJ were trained by
using a large learning sample at the stage of abstract screening
and manuscript review. One of the senior investigators (AS)
reviewed a 20% random sample of excluded studies and all
included abstracts for quality control. The process led to 100%
agreement among the three authors.
We abstracted information on study design, quality, number of
hips (patients), date of procedure, age, sex, number of surgeons
and centres, diagnosis (osteoarthritis or avascular necrosis),
mean follow-up, percentage follow-up, and information on the
manufacturer. The main outcome measures included any
functional outcome and occurrence of revision.
Methodological quality
To evaluate quality of included studies we used four important
criteria that lead to conclusions of overall perception of the risk
of bias. As masking/blinding of surgeons in these trials is not
applicable, we considered “randomised” study description;
description of a correct randomisation procedure; masking of
patients and outcome assessors; intention to treat analysis; and
allocation concealment (methods such as sealed envelope,
central telephone) including the time of the announcement of
the allocation (in the operating room v before). We used the
STROBE criteria to assess the quality of the observational
studies.
19 Quality was classified as high (low risk of bias),
intermediate(moderateriskofbias),andlow(highriskofbias).
No formal tool or score was developed. The high quality
classification was based on adequate description of
randomisation or comparator group, units of randomisation
(patient v hip), masking (participants, outcome assessors), and
allocation concealment. If studies did not report any of the
criteria and described potentially problematic designs (such as
questionable exclusion of patients, not describing the group
balance regarding prognostic factors), we categorised these
studiesaslowquality.Otherclassifications(moderate,moderate
to high, moderate to low) were based on overall clinical and
critical judgments of proximity to high or low quality. Thus,
the decision to classify studies into the three categories was
based on overall perception of risk of bias after evaluation of
the quality criteria, descriptions related to design, and
presentations of data.
Publication bias
Whilepublicationbiasisapplicabletoanytopicarea,webelieve
that comparative surgical trials in orthopaedics are relatively
rare,andpapersforsuchcomparisonsarelikelytobesubmitted
and accepted by journals regardless of the findings. Another
possible publication bias might be related to selective reporting
ofoutcomes.Manystudiesdidnotreportalloutcomesofinterest
to us (particularly revision surgery).
Qualitative and quantitative analyses
Weevaluatedclinicalheterogeneity(diversity)amongthetrials
by abstracting data on included populations and evaluating
definitions of outcomes (often not reported). Functional
outcomesincludeddiseasespecificHarrishipscoreandgeneral
quality of life measures (SF-12). We collected data on number
of events (categorical data), scores (continuous data), relative
risks (when reported) and their 95% confidence intervals, and
P values. We report evidence for alternative bearings (such as
metal on metal and ceramic on ceramic) compared with
traditionalbearings(suchasceramiconpolyethyleneandmetal
on polyethylene) bearings. We also report any comparative
evidence between two traditional bearings (such as ceramic on
polyethylene versus metal on polyethylene) and between
alternativebearings(ceramiconceramicversusmetalonmetal).
Formal meta-analysis was considered in one instance of
relativelycompletereportingoffunctionaloutcome.Theresults
from each study are expressed as a mean difference with 95%
confidenceintervalsandcombinedwitharandomeffectmethod.
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RESEARCHStatistical heterogeneity was evaluated with I
2 estimates. Rev
Man 5.1 software was used for statistical analyses.
Results
Studies and populations
We identified and reviewed 3254 abstracts (see appendix 3 on
bmj.com). We identified 18 randomised trials and comparative
observational studies.
20-40 One study (Capello and colleagues)
included both randomised and non-randomised arms and is
represented twice in the tables.
30-32 37 There were 3139 patients
and 3404 hips enrolled in 18 comparative studies (table 1)⇓.
The mean age ranged from 42 to 71, and only five out of 18
comparativestudiesreportedstandarddeviation.Theproportion
of women was 26-88%; four studies did not report information
on sex.
28 34 36 39 None of the studies reported age specific or sex
specific analyses, and none reported race or patients’
comorbidity, such as diabetes and obesity. Only 13 reported
information on diagnosis, and osteoarthritis was the most
prevalent diagnosis in 12 studies (range 41-100%). One study
predominantlyenrolledpatientswithavascularnecrosis,
35which
was the second most common diagnosis in the trials. Reported
outcomesincludedfunctionaloutcomessuchasdiseasespecific
Harrishipscore,generalqualityoflifemeasure(suchasSF-12),
and revision surgery. Follow-up ranged from three months to
8.1 years (table 1)⇓.
Methodological quality
Four studies were classified as moderate to high quality, five
studies as moderate quality, and six studies as low quality.
Subgroup analyses based on quality were not informative
because of homogenous results and relatively few studies
contributing to each comparison. We report the quality
informationtoillustratetheoveralllackofappreciationofdesign
and analysis reporting in the comparative studies of bearing
surface.
Patients’ outcomes: Harris hip score
The Harris hip score (with higher scores indicating better
outcomes) was the most commonly used functional outcome
measurement and was reported by 16 out of 18 studies (table
2⇓). Only 10 studies, however, reported both baseline and
follow-upmeasurements;sixreportedonlypostoperativescores.
Metal on metal v traditional bearing surfaces—All studies had
follow-up measurements, but one study did not report
preoperative scores (table 2).⇓ Four studies compared metal on
metal bearing with metal on polyethylene at two years. The
reportingwasrelativelycompleteinthesestudies,andthescores
were combined. The combined estimate favoured metal on
polyethylene bearing. There was a significant 2.4 points higher
score(95%confidenceinterval4.5to0.3)associatedwithmetal
onpolyethylenecomparedwithmetalonmetalbearing(fig1⇓).
Three studies reported Harris hip scores beyond two years: two
studies compared metal on metal with metal on polyethylene
and another with ceramic on polyethylene (fig 2⇓). The
individualandcombinedscoresweresimilarinallthreestudies
for all bearings.
Ceramic on ceramic v traditional bearing surfaces—Five
studiescomparedceramiconceramicbearingswithceramicon
polyethylene bearing. Four studies had both baseline and
follow-upmeasurements,andonestudyhadmeasurementsonly
after surgery. Two studies compared ceramic on ceramic with
metalonpolyethylenebearingandhadmeasurementsonlyafter
surgery. One of the studies was part of the pre-market
application process and had a randomised and non-randomised
arm(andhenceisrepresentedtwiceintable2).
30-32 37TheHarris
hip scores were similar at baseline and follow-up in all groups
that compared ceramic on ceramic with other bearing surfaces.
Ceramiconpolyethylenevmetalonpolyethylene—Twostudies
comparedceramiconpolyethylenewithmetalonpolyethylene,
and one of the studies had only follow-up measurement. There
were no differences in Harris hip scores.
Metal on metal v ceramic on ceramic—One study compared
bothalternativebearingsurfacesanddidnotfindanydifference
in scores at follow-up.
24 The study included only 28 hips
(patients) and was likely to be underpowered to determine any
differences between the groups.
Patients’ outcomes: other functional scores
Five studies compared metal on metal with other bearing
surfaces(table3⇓).Fourofthesecomparedmetalonmetalwith
metal on polyethylene and one study compared metal on metal
withceramiconceramic.Onestudyreportedsubstantiallybetter
physical functioning after surgery associated with metal on
polyethylene compared with metal on metal.
28
One study compared ceramic on ceramic with ceramic on
polyethylene, and there was no difference between the groups.
Patients’ outcomes: revision occurrence after
hip replacement
Evidence from comparative studies
Tencomparativeevaluationsreportedinformationonrevisions,
and only seven reported data on dislocations. No study
specifically reported aseptic loosening.
Metal on metal v traditional bearing surfaces—Two studies
compared metal on metal with metal on polyethylene bearing
and found no difference in occurrence of revisions. Two other
studies compared metal on metal with ceramic on polyethylene
bearing, and one of these studies
33 reported substantially higher
occurrenceofdislocationintheceramiconpolyethylenegroup.
Occurrence of dislocation was not different in the other three
studies.
Ceramic on ceramic v traditional bearing surfaces—Seven
comparative studies reported this information. Two studies
compared ceramic on ceramic with metal on polyethylene
bearing. As described before, one of the studies (Capello and
colleagues)includedbothrandomisedandnon-randomisedarms
(represented twice in table 4⇓).
30-32 37 This study reported
substantially lower occurrence of revision in the ceramic on
ceramic arms compared with metal on polyethylene arm. Five
studies compared ceramic on ceramic with ceramic on
polyethyleneandfoundnoqualitativeorquantitativedifferences
between the groups in terms of revision occurrence.
Ceramic on polyethylene v metal on polyethylene—One
comparative study compared ceramic on polyethylene with
metal on polyethylene and found no difference in revision
occurrence.
Metal on metal v ceramic on ceramic—There were no
comparative studies discussing occurrence of revision.
Emerging evidence on revision from national
registries
We reviewed the annual reports of 29 national and regional
registries.Fivenationalregistries
8-10 41 42includingover830000
surgeries reported information on bearing surface, and one US
study including over 57 000 surgeries reported data from the
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2011;343:d7434 doi: 10.1136/bmj.d7434 (Published 29 November 2011) Page 3 of 12
RESEARCHMedicare database.
2 Some of the large national registries, such
astheSwedishregistry,
43reportedinformationoneveryimplant
used in the country but did not stratify by bearing surface.
National registries provided important quantitative data, but
they varied in their methods of risk adjustment. While we
considered national registry reports as comparative studies, we
did not evaluate quality because of lack of information on
methods.
Main findings
Metal on metal was associated with higher occurrence of
revision compared with metal on polyethylene in the adjusted
analyses of three national registries: Australian, New Zealand,
andEnglandandWalesNationalRegistries(includingover720
000 patients).
8-10 Three other smaller registries (including the
Center for Medicare and Medicaid Services (CMS) database)
did not report such results (fig 3⇓).
Ceramic on ceramic was associated with a higher occurrence
of revision than metal on polyethylene in the adjusted analyses
oftheNewZealandNationalRegistry.
9Fiveregistries(including
the CMS database) did not report any difference.
Ceramic on polyethylene was associated with a higher
occurrence of revision than metal on polyethylene in the New
ZealandNationalRegistrybutaloweroccurrenceintheEngland
andWalesNationalRegistry.Threeothernationalregistriesdid
not report any difference (ceramic on polyethylene implant
category was not available in the CMS database).
Discussion
Functional outcomes, traditionally thought of as primary
effectiveness outcomes, were no different among patients
receivinghipreplacementswithvariousbearings.Weconducted
this systematic evidence review as part of the new project
initiated by the Food and Drug Administration to create a
frameworkforpost-marketevaluationoforthopaedicimplants.
This systematic evaluation helps to deal with evidence gaps in
comparisons of hip bearing surfaces.
We found some evidence for lower Harris hip scores (by 2.4
points) at two year follow-up for metal on metal bearing
comparedwithmetalonpolyethylene.Therewasalsoevidence
from one trial that patients receiving metal on metal implants
havealowerqualityoflife(functionalcomponent)thanpatients
receiving metal on polyethylene bearing.
28 Though these
differences are small and might not be clinically relevant, they
arestillvaluablefindingstobeconsideredforfuturehypothesis
generation.
Evidence on implant revision did not favour metal on metal
implants.Whileonestudyreportedfewerdislocationsassociated
with metal on metal implants, three other trials did not support
this finding, and the three largest national registries reported
substantiallyhigheroccurrenceofrevisionassociatedwithmetal
onmetalimplantscomparedwithmetalonpolyethylenebearing
(fig 2)⇓.
One medium size comparative clinical trial reported a
substantially lower rate of revision associated with ceramic on
ceramic implants compared with metal on polyethylene
implants.
30 This conflicts with results reported in national
registries (fig 2⇓). Five national data sources/registries did not
report any difference between the ceramic on ceramic and
traditional bearings, and a large registry report from New
Zealandfavouredceramiconpolyethylene(traditionalbearing)
compared with ceramic on ceramic surfaces.
Comparison with other studies
To our knowledge this is the first systematic appraisal of
assessment of clinical outcomes after hip replacement with
various bearing surfaces. We did not summarise the evidence
related to metal sensitivity or toxicity, but our findings related
to clinical outcomes of metal on metal implants are augmented
by reports that show severe metallosis associated with such
implants.
14 Concerns regarding the effects of metal ions have
been noted after a landmark paper by MacDonald et al
36 that
noteda5.3-foldincreaseinerythrocytecobalt,a35-foldincrease
in urinary cobalt, and a 17-fold increase in urinary chromium
concentrations in patients who received metal on metal hip
replacements compared with those who received metal on
polyethylene.
Strengths and limitations of study
We found 18 comparative studies of bearing surface and six
national data source/registry reports and comprehensively
summarised the strengths and limitations of current data. The
overall quality of reporting in the comparative studies was less
thanadequateinthetrialsofbearingsurface.Manyinvestigators
did not report their power to detect minimally important
differencesamonggroupsandoftenomittedstandarddeviations
and range of scores observed. In addition, few studies were
adequately powered or reported subgroup analyses by age, sex,
underlying aetiology, or femoral head size. Classification of
polyethylene inserts used in hip replacement also needs
harmonisation; the various terms used to define cross linked
polyethylenehindersubgroupanalyses.Ourreviewwaslimited
to English language publications, and there is chance of
publicationbias.Therewassubstantialheterogeneityinregistry
evidence. Formal data pooling from registries will require
harmonisation of data definitions and analytical methods.
Policy implications
Changing technology, the need to have large numbers of
patients, long term follow-up to establish the safety, and short
and long term outcomes reported by patients to establish the
effectiveness all lead to a lack of strong evidence in
orthopaedics. For example, patients who receive hip implants
oftenrequirerevisionsurgerywithin10years,whentheimplants
failbecauseofinfection,dislocation,wear,instability,loosening,
orothermechanicalfailures.Inaddition,clinicaltrialsassessing
bearingsurfacesareconductedinrelativelyuniqueenvironments
defined by skilled surgeons operating at high volume centres
and often concentrating on clinical and radiological indirect
measures of device safety and effectiveness. In general this is
a reflection of the current state of research in implantable
devices, where comparative trials are rare and often not
applicable.
44
Registries are likely to fill the evidence gap in the immediate
future. Large registries or networks of registries capturing
various orthopaedic devices are particularly important for
evaluation of comparative outcomes and active surveillance.
Only large longitudinal multinational registries can provide
denominatordataforadverseeventsrelatedtospecificimplants
and allow proper conduct of comparative safety and
effectiveness studies, particularly for rare end points. Current
registry annual reports that include comparative evaluations,
however,arenotharmonisedintermsofmethodsandreporting.
Accordingly, the findings are tentative. To deal with this
limitation the US Food and Drug Administration Center for
Devices and Radiologic Health started an important initiative
called the International Consortium of Orthopaedic Registries,
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consortiumoforthopaedicregistries.Theconsortiumrepresents
more than 15 countries that have existing registries with a
mission to improve the safety and effectiveness of orthopaedic
devices and procedures through collaboration. Currently, these
internationalregistriesincludedmorethan3500000orthopaedic
surgeries capturing all implantable devices on the market.
Conclusions
There is limited evidence regarding comparative effectiveness
of various hip implant bearings, and the results do not indicate
any advantage for metal on metal or ceramic on ceramic
implants compared with traditional bearings. A large and high
quality randomised controlled trial of bearing surfaces in total
hip replacement needs to be conducted before any claims of
benefitaremade.Untilthennationalregistriesprovideimportant
real world data that are critical for the safety and future
comparative safety and effectiveness evaluation.
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RESEARCHWhat is already known on this topic
There have been severe cases of accumulation of metal ions in tissues of patients with metal on metal hip implants
Metal on metal and ceramic on ceramic hip implants might not be associated with any advantage compared with traditional bearings
such as metal on polyethylene or ceramic on polyethylene
What this study adds
Disease specific functional outcomes such as Harris hip score and general quality of life measures were no different between patients
with metal on metal or ceramic on ceramic hip implants compared with traditional hip implants
There is some evidence of higher rates of revision surgery associated with metal on metal implants compared with metal on polyethylene
implants
While an investigational device exemption trial reported fewer revisions associated with ceramic on ceramic implants, the emerging
evidence from national registries does not support these results
Tables
Table 1| Baseline data in comparative studies of various bearing surfaces in hip replacement systems
Manufacturer
(%)
follow-up
Mean
follow-up
(years)
%
osteo-arthritis
(avascular
necrosis)
%
women
Mean(SD,
range)
age
(years)
Site, surgeon,
centre
Date of
procedure
No of
hips
(patients)
Study
quality Design Study
Metal on polyethylene v metal on metal
Zimmer (previously
Sulzer)
100 24 months
(22-27)
100 (0) 50 65 (NA,
40-75)
Single
surgeon,
single centre
Oct
1998-Jan
2001
54 (54) Moderate Randomised Dahlstrand,
2009,
Sweden
27
DePuy
Orthopaedics
86 NA (6
months-2
years)
NA NA NA (40-80) NA Oct
2003-Oct
2005
91 (91) Moderate Randomised Engh, 2009,
US
28
Johnson &
Johnson
72 43 months 66 (20) 43 54.4 (NA) Multi-surgeon,
multicentre
March
1997-July
2000
171 (171) Moderate Randomised Jacobs, 2004,
US
40
BioMet 98 3.2
(2.2-3.9)
NA NA NA Multi-surgeon,
multicentre
March
1998- Nov
1999
41 (41) Moderate Randomised MacDonald,
2003, US
36
Biomet 97 5.6
(4.2-7.1)
NA 79 71 (8, NA) Multi-surgeon,
multicentre
NA 200 (195) Moderate Randomised Zijlstra, 2009,
Netherlands
29
Ceramic on polyethylene v metal on metal
Johnson &
Johnson
100 3 months
(NA)
100 (0) 51 56.1 (NA,
24-69)
Single
surgeon,
single centre
C-P 1995-8;
M-M
1998-2002
249 (229) Moderate Comparative Clarke, 2003,
UK
33
Zimmer (previously
Sulzer)
NA 5 (NA) NA NA 60 (NA,
27-85)
Multi-surgeon,
multicentre
Aug 1999
start
615 (561) Low Randomised Dorr, 2004,
US
34
Ceramic on ceramic v metal on polyethylene
Zimmer 51 months 84 (5) 26 54.8 (6.8) Multi-surgeon,
single centre
Jan
2003-April
2008
157 (150) Moderate
to high
Randomised Bascarevic,
2010, Serbia
38
Stryker
Orthopaedics
93 8 (5-NA) 82 (15) 36 53 (NA) Multi-surgeon,
multicentre
Oct
1996-Oct
1998
289 (278) Moderate
to high
Randomised Capello,
2008,
30
D’Antonio,
2005, US
31
Stryker
Orthopaedics
NA 6.5 (5-NA) NA 31 51.8 (NA) Multi-surgeon,
multicentre
Sep
1999-Sep
2000
186 (174) Moderate
to high
Comparative Capello
“partial,”
2008, addition
of 4th system,
Trident, US
30
Ceramic on ceramic v ceramic on polyethylene
CeramTec, DePuy,
DePuy-Johnson &
Johnson
88 31 months
(21-49
months)
88 (6) 48 56.7 (NA,
20-75)
Multi-surgeon,
multicentre
2003 264 (263) Moderate
to high
Randomised Hamilton,
2010, US
20
DePuy 100 5.6 (5-7) 10 (63) 34 45.3 (NA,
21-49)
Single
surgeon,
single centre
Jan 2000-
Jan 2002
200 (100) Moderate
to high*
Randomised Kim, 2009,
South Korea
35
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RESEARCHTable 1 (continued)
Manufacturer
(%)
follow-up
Mean
follow-up
(years)
%
osteo-arthritis
(avascular
necrosis)
%
women
Mean(SD,
range)
age
(years)
Site, surgeon,
centre
Date of
procedure
No of
hips
(patients)
Study
quality Design Study
Wright Medical 93 96 months
(1-10)
41 (11) NA 42.1 (8.0) 1-2 surgeons,
single centre
Oct
1997-Oct
1999
56 (55) Moderate Randomised Lewis, 2010,
Canada
39
BioMet NA 6.1
(2.1-9.0)
84 (9) 46 58 (NA) Single
surgeon
June 2000 89 (80) Low Randomised Lombardi,
2010, US
21
Braun-Aesculap,
CeramTec
65 8.1
(7.1-9.2)
53 (NA) 42 58.7 (7.8,
NA)
Multi-surgeon,
single centre
1997-9 66 (66) Moderate
to high
Randomised Ochs, 2007
Germany
22
Zimmer/CeramTec 99 2 77 (17) 45 54 (12,
23-76)
Multi-surgeon Oct 1999-
Jan 2003
472 (429) Low Randomised Poggie, 2007,
US
23
Ceramic on polyethylene v metal on polyethylene
Japan Medical
Material
100 5 (4.8-5.4) 69 (18) 88 61.1 (NA,
30-78)
Multi-surgeon July
2001-July
2003
62 (60) Low Randomised Kawate,
2009, Japan
25
DePuy,
DePuy-Johnson &
Johnson
92 5 (NA) NA 54 64 (NA,
50-76)
Multi-surgeon,
multicentre
1996-8 114 (114) Low Randomised von
Schewelov,
2005,
Sweden
26
Ceramic on ceramic v metal on metal
Zimmer,CeramTec NA 1 (NA) 93 (7) 64 62.2 (NA,
32-81)
NA Nov
2000-Feb
2002
28 (28) Low Randomised Grubl, 2006,
Austria
24
NA=not available (not applicable or not provided).
*In this study each person served as his/her own control (bilateral procedures). Functional outcomes are challenging to determine but potentially possible. Uncertainty
about surgeon’s involvement in functional outcome measurement leads to less than perfect quality classification.
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RESEARCHTable 2| Harris hip score in comparative studies of bearing surfaces. Figures are mean scores (higher scores indicating better outcomes)
(SD and range when available) for longest period of follow-up reported
Ceramic on polyethylene Metal on polyethylene Ceramic on ceramic Metal on metal
Study Postoperative Preoperative Postoperative Preoperative Postoperative Preoperative Postoperative Preoperative
NA NA 95.9 (4.8) 38.9 (12.7) NA NA 92.8 (12.9) 38.1 (10.9) Dahlstrand, 2009*,
Sweden
27
NA NA 96 (6) Done but NA NA NA 93.5 (9) Done but NA Engh, 2009, US
28
NA NA 96.1 (65-100) 43 NA NA 95.4 (65-100) 42 Jacobs, 2004, US
40
NA NA 89.2 (12.5) 46.6 (12.4) NA NA 91.6 (11.5) 46.5 (13.4) MacDonald, 2003,
US
36
NA NA 87 (13) 46 (13) NA NA 90 (7) 48 (15) Zijlstra, 2009†,
Netherlands
29
93.5 (11,
41-100)
NA NA NA NA NA 93.5 (12,
14-100)
NA Dorr, 2004, US
34
NA NA 93.8 NA 95.1 NA NA NA Bascarevic, 2010,
Serbia
38
NA NA 96.4 NA 96.35 NA NA NA Capello, 2008,
30
D’Antonio, 2005,
31
US
NA NA 96.4 NA 95.7 NA NA NA Capello, 2008,
addition of 4th
system, Trident,
US
30
93.8 50.7 NA NA 94.4 50.6 NA NA Hamilton, 2010,
US
20
94 (86-100) 41 (9-51) NA NA 93 (85-100) 39 (6-47) NA NA Kim, 2009, South
Korea
35
92 (49-100) 48 (6-69) NA NA 90 (50-100) 51 (6-68) NA NA Lombardi, 2010,
US
21
89 (12.1) NA NA NA 91 (21.6) NA NA NA Ochs, 2007,
Germany
22
93 (51-100) 43 (10-78) NA NA 92 (36-100) 45 (14-91) NA NA Poggie, 2007, US
23
89 (58-100) 43 (15-75) 91(60-100) 47 (28-77) NA NA NA NA Kawate, 2009,
Japan
25
91.3 (10.5) NA 91.7 (11.2) NA NA NA NA NA von Schewelov,
2005, Sweden
26
NA NA NA NA 86.6 (41.5-100) 58.4
(24.4-82.3)
85.1 (61.1-100) 50.4
(15.1-71.4)
Grubl, 2006,
Austria
24
NA=not available (not applicable or not provided).
*Significant difference favouring metal on polyethylene compared with metal on metal at 12 months but not at 24 months after surgery.
†Measurements at two and five years. Only score at five years reported here (fig 2 shows both two and five year scores).
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RESEARCHTable 3| Other functional outcomes in comparative studies of various bearing surfaces in hip replacements. Figures are mean (SD) scores
on each scale
Ceramic on polyethylene Metal on polyethylene Ceramic on ceramic Metal on metal
Study Postoperative Preoperative Postoperative Preoperative Postoperative Preoperative Postoperative Preoperative
Dahlstrand, 2009, Sweden
27
NA NA 77 (19.3)* 40 (24.5) NA NA 67.2 (26.9)* 32.6 (22.6) SF-36: PF
NA NA 76.7 (27.9)* 39.3 (19.2) NA NA 67.9 (31.7)* 33.3 (19.4) SF-36: BP
Engh, 2009, US
28
NA NA 89 (19) NA NA NA 88 (15) NA WOMAC
NA NA 51 (9)† NA NA NA 46.2 (11.6)† NA PCS
(SF-12)
NA NA 55 (6)‡ NA NA NA 56.8 (7)‡ NA MCS
(SF-12)
MacDonald, 2003, US
36
NA NA 19.9 (18.9) 59.1 (14.5) NA NA 17.3 (15.1 ) 58.7 (15.3) WOMAC
NA NA 45.5 (11.7) 31.1 (4.7) NA NA 47.2 (9.6) 32.8 (10.2) PCS SF-12
NA NA 53.3 (11.7) 53.6 (11.6) NA NA 55.9 (6.2) 53.5 (9.6) MCS SF-12
Zijlstra, 2009, Netherlands
29
NA NA 18 (8) 40 (8) NA NA 19 (8) 40 (8) Oxford hip
score
Lewis, 2010, Canada
39
22.8 16.2 NA NA 22.9 15.8 NA NA St Michael’s
score
Grubl, 2006, Austria
24
NA NA NA NA 7/10 points§ NA 7/10 points§ NA UCLA
activity score
UCLA=University of California, Los Angeles; PF=physical function; BP=bodily pain; PCS=physical component score; MCS=mental component score; WOMAC=Western
Ontario and McMaster Universities activity score; NA=not available (not applicable or not provided).
*At 24 months.
†Difference significant (P=0.03). Mean score for metal on metal calculated from two groups (28 mm and 36 mm head sizes).
‡Difference not significant. Mean score for metal on metal calculated from two groups (28 mm and 36 mm head sizes).
§At 12 months.
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RESEARCHTable 4| Revision surgery and reported dislocation in comparative studies of various bearing surfaces in hip replacements. Figures are
numbers (percentages)
Ceramic on polyethylene Metal on polyethylene Ceramic on ceramic Metal on metal
Study
Reported
dislocation
Revision
surgery
Reported
dislocation
Revision
surgery
Reported
dislocation
Revision
surgery
Reported
dislocation
Revision
surgery
NA NA 1/76 (1.3) 1/76 (1.3) NA NA 1/95 (1.1) 1/95 (1.1) Jacobs, 2004, US
40
NA NA NA 1/92 (1.1) NA NA NA 3/98 (2.9) Zijlstra, 2009,
Netherlands
29
9/140 (6.4)* NA NA NA NA NA 1/109 (0.9)* NA Clarke, 2003, UK
33
12/304 = 3.9) 8/304 (2.6) NA NA NA NA 12/304 (3.9) 10/311 (3.2) Dorr, 2004, US
34
NA NA 2/75 (2.7) 2/75 (2.7) 1/82 (1.2) 2/82 (2.4) NA NA Bascarevic, 2010,
Serbia
38
NA NA 7/165 (4.2) 10/165 (6.1)* 10/349 (2.9) 6/349 (1.7)* NA NA Capello, 2008,
30
D’Antonio, 2005, US
31
NA NA 7/165 (4.2) 10/165 (6.1)* NA 1/186 (0.5)* NA NA Capello, 2008, addition
of 4th system, Trident,
US
30
4/87 (4.6) 2/87 (2.3) NA NA 5/177 (2.8) 4/177 (2.3) NA NA Hamilton, 2010, US
20
2/100 ( 2) NA NA NA 1/100 (1) NA NA NA Kim, 2009, South
Korea
35
NA 1/26 (3.8) NA NA NA 1/30 (3.3) NA NA Lewis, 2010, Canada
39
NA 3/45 (6.7) NA NA NA 3/44 (6.8) NA NA Lombardi, 2010, US
21
NA 2/157 (1.3) NA NA NA 4/315 (1.3) NA NA Poggie, 2007, US
23
NA 3/56 (5.3) NA 1/58 (1.7) NA NA NA NA von Schewelov, 2005,
Sweden
26
NA= not available (not applicable or not provided).
*Significant group difference.
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RESEARCHFigures
Fig 1 Harris hip scores at two years (top) after hip implants with metal on metal versus metal on polyethylene bearings.
Zijlstra et al
29 measured score at both 24 months and 60 months
Fig 2 Harris hip score beyond two years after hip implants with metal on metal versus metal on polyethylene or ceramic on
polyethylene bearings. Jacobs et al
40 assessed score at mean 43 months while Dorr et al
34 assessed score at 60 months.
Zijlstra et al
29 measured score at both 24 months and 60 months. SD of mean imputed for Jacobs et al and sensitivity
analyses performed; varying estimates of SD did not change overall estimate of effect
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RESEARCHFig 3 Qualitative evidence reported in six national data sources/registries (Australia, New Zealand, England and Wales,
Italy (Emilia-Romagna), Kaiser and CMS databases)
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